Regenxbio Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Rockville MD United States (2009)

Organization Overview

First Clinical Trial
2017
NCT03066258
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Regenxbio Inc.